FDA Drug recall D-0047-2024
Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPh…
- FDA Drug
- Class I
- terminated
- Published 2023-10-25
On 2023-10-25 the FDA classified a Class I recall of Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPh… by Vistapharm, citing microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0047-2024 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2023-10-18 |
| Published | 2023-10-25 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Vistapharm |
| Distribution | US |
Product
Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16
Reason
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
Identifiers
| code_info | Lot#: 810300, Exp 10/2023 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0047-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.